PTPRC and neoplasm: While the non-selective ADAM10 mAb 4A11 bound to both normal colon and tumour epithelial (CD45 negative, EpCam positive) cells, 8C7 preferentially bound to tumour cells, suggesting selective targeting of active ADAM10 in the tumour (Figure 2A).